Avalo Therapeutics, Inc.
AVTX
$19.50
$0.050.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 388.18% | -16.62% | -11.90% | -1.45% | -9.42% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.79% | -3.30% | 223.19% | 12.40% | 3.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -66.67% | 297.30% | -58.89% | 350.00% | -67.74% |
| Total Current Assets | 359.25% | -15.63% | -7.52% | -1.16% | -9.26% |
|
|
|||||
| Total Current Assets | 359.25% | -15.63% | -7.52% | -1.16% | -9.26% |
| Net Property, Plant & Equipment | -23.20% | -18.48% | -15.13% | -20.99% | -27.71% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -12.86% | 0.00% | 0.00% | 60.31% |
| Total Assets | 391.35% | -14.23% | -6.91% | -1.17% | -8.62% |
|
|
|||||
| Total Accounts Payable | 840.17% | 159.85% | -71.10% | -79.97% | 247.43% |
| Total Accrued Expenses | -30.91% | -12.05% | 83.35% | 19.13% | 54.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.22% | -16.33% | -10.50% | -9.13% | -8.37% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -60.08% | 1.39% |
| Total Other Current Liabilities | -- | -- | -- | -60.08% | 1.39% |
| Total Current Liabilities | 82.17% | -10.36% | 62.32% | -13.90% | 64.90% |
|
|
|||||
| Total Current Liabilities | 82.17% | -10.36% | 62.32% | -13.90% | 64.90% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -70.09% | -40.61% | -28.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.14% | -2.29% | -19.75% | 102.85% | 25.30% |
| Total Liabilities | 33.45% | -5.52% | -0.43% | 52.45% | 38.35% |
|
|
|||||
| Common Stock & APIC | 77.78% | 0.94% | 0.99% | 3.44% | 0.55% |
| Retained Earnings | -7.77% | -4.38% | -3.16% | -7.58% | -5.42% |
| Treasury Stock & Other | -9,616.67% | -108.82% | 65.85% | 220.59% | -- |
| Total Common Equity | 556.70% | -17.74% | -9.28% | -12.46% | -14.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 556.70% | -17.74% | -9.28% | -12.46% | -14.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 556.70% | -17.74% | -9.28% | -12.46% | -14.71% |
|
|
|||||